DKSH Performance Materials Strengthens its North American Presence With the Acquisition of Terra Firma

With the acquisition of Terra Firma, DKSH creates a scalable platform for growing its presence in Performance Materials in North America.

Terra Firma has national coverage in the USA and Canada and is representing premier suppliers in its core segments of CASE (Coatings, Adhesives, Sealants, and Elastomers), plastics and construction, agrochemicals, health and nutrition, as well as  personal care. The addition of a strong player in the North American Industrial specialty chemicals distribution sector is a major contribution to DKSH’s Performance Materials business and is complementary to DKSH’s existing specialty industrial business globally. DKSH’s expertise in the distribution of life sciences ingredients offers a strong base to expand further into food, pharma, and personal care in North America.

Terra Firma currently operates with around 100 highly skilled professionals across the region and has offices in Los Angeles, Dallas, Baltimore, and Toronto. Terra Firma expects net sales of around USD 240 million in 2022. The transaction, which is expected to close towards the end of year, will be valued at USD 360 million enterprise value. DKSH will acquire at least 80% of Terra Firma with the remainder held by the company’s existing management team. The transaction is EPS-accretive and will be financed via debt and cash.

Stefan Butz, DKSH’s CEO, commented: “Expanding our presence in the North American market has been a strategic focus for our Performance Material business. Terra Firma’s teams operate coast to coast and will accelerate our expansion into the North American specialty chemical distribution market, while we will provide their clients access to our global network. The Terra Firma acquisition is a milestone in the transformation of DKSH Performance Materials to becoming a global player.”

Tim Fetters, Terra Firma’s CEO, added: “Terra Firma has earned an excellent market reputation by delivering value and significant growth to its customers and suppliers. By joining DKSH, we will be able to leverage our growth platform further and increase our presence in life sciences.”